Jane Street Group, LLC Standard Biotools Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Standard Biotools Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 181,814 shares of LAB stock, worth $332,719. This represents 0.0% of its overall portfolio holdings.

Number of Shares

181,814

Previous 242,154 24.92%

Holding current value

$332,719

Previous $428,000 18.22%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.42 - $2.35 $85,682 - $141,799	-60,340 Reduced 24.92%	181,814 $350,000
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.92 $1.88 Million - $3.33 Million	-1,141,543 Reduced 82.5%	242,154 $428,000
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $2 Million - $2.97 Million	1,067,748 Added 337.95%	1,383,697 $3.75 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $445,702 - $765,262	280,316 Added 786.68%	315,949 $698,000
Q3 2023 Nov 14, 2023	SELL	$1.9 - $3.05 $5,477 - $8,793	-2,883 Reduced 7.49%	35,633 $103,000
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $328,424 - $571,950	-223,418 Reduced 85.3%	38,516 $74,000
Q1 2023 May 15, 2023	BUY	$1.3 - $2.24 $244,691 - $421,621	188,224 Added 255.36%	261,934 $510,000
Q4 2022 Feb 14, 2023	BUY	$0.93 - $1.52 $45,069 - $73,662	48,462 Added 191.94%	73,710 $86,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $174,170 - $326,174	-158,337 Reduced 86.25%	25,248 $28,000
Q2 2022 Aug 16, 2022	BUY	$1.6 - $3.99 $262,691 - $655,086	164,182 Added 846.17%	183,585 $294,000
Q1 2022 May 17, 2022	SELL	$2.8 - $3.96 $57,803 - $81,750	-20,644 Reduced 51.55%	19,403 $70,000
Q4 2021 Feb 15, 2022	SELL	$3.63 - $6.13 $25,014 - $42,241	-6,891 Reduced 14.68%	40,047 $157,000
Q3 2021 Nov 16, 2021	SELL	$5.5 - $7.41 $235,163 - $316,829	-42,757 Reduced 47.67%	46,938 $309,000
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $140,818 - $205,562	32,372 Added 56.47%	89,695 $553,000
Q1 2021 May 18, 2021	SELL	$3.94 - $7.09 $511,459 - $920,367	-129,812 Reduced 69.37%	57,323 $259,000
Q4 2020 Feb 17, 2021	BUY	$5.45 - $8.65 $946,043 - $1.5 Million	173,586 Added 1281.17%	187,135 $1.12 Million
Q3 2020 Nov 17, 2020	BUY	$4.34 - $11.43 $58,802 - $154,865	13,549 New	13,549 $101,000
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $31,723 - $70,620	-13,793 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.63 - $12.15 $63,861 - $167,584	13,793 New	13,793 $64,000
Q4 2018 Feb 15, 2019	SELL	$7.18 - $8.83 $124,070 - $152,582	-17,280 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.92 - $8.35 $28,463 - $40,146	4,808 Added 38.55%	17,280 $129,000
Q2 2018 Aug 15, 2018	BUY	$4.86 - $6.24 $60,613 - $77,825	12,472 New	12,472 $74,000

Others Institutions Holding LAB

# of Institutions

142

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $144M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Standard Biotools Inc. Transaction History